| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gluck Frederick W serves as a Director at CTMX. Across recent SEC filings that breaks down to 2 buys and 8 sells. Those positions are worth an estimated $926K at current prices.
The biggest single holding is CTMX (~$926K) as Director. The recent filings there lean toward selling, a net 45,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2018 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 5,000 | $31.93 | $159,641.50 | -1.8% | |
| Mar 2, 2018 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 16,181 | $30.00 | $485,465.60 | -5.5% | |
| Feb 28, 2018 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 3,819 | $30.00 | $114,570.00 | -1.3% | |
| Jan 5, 2018 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 10,000 | $25.01 | $250,078.00 | -3.3% | |
| Dec 26, 2017 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 5,000 | $22.29 | $111,425.50 | -1.6% | |
| Oct 4, 2017 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 10,000 | $24.27 | $242,680.00 | -3.1% | |
| Sep 26, 2017 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 5,000 | $17.30 | $86,476.00 | -1.5% | |
| Jun 26, 2017 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 5,000 | $14.61 | $73,050.00 | -1.5% | |
| Oct 14, 2015 | CTMX Cytomx Therapeutics, Inc. | Director | Buy | 15,000 | $12.00 | $180,000.00 | +10.9% |